Randomized Phase II Study for Evaluation of Efficacy and Safety of Maintenance Treatment With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction Treatment With mFOLFOX6 Plus Panitumumab and Re-induction With mFOLFOX6 Plus Panitumumab in Case of Progression for First-line Treatment of Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Panitumumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms PanaMa
- 11 Oct 2016 Trial design presented at 41st European Society for Medical Oncology Congress.
- 02 Mar 2016 Planned number of patients changed from 280 to 380 as per European Clinical Trials Database record.
- 28 Jan 2014 Status changed from not yet recruiting to recruiting as reported by European Clinical Trial Database Record..